Monday, September 19, 2016

BRIEF-Active Biotech updates on laquinimod development

* Active Biotech update on laquinimod development: U.S, Food

and Drug Administration rescinds special protocol assessment for

laquinimod

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)